PROTALIX BIOTHERAPEUTICS INC

Ticker: PLX CUSIP: 74365A309 Class: Common Stock

Connor, Clark & Lunn Investment Management Ltd.'s Holding History (CIK: 0001596800)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 232,093 Value ($000) $418 Avg Close $2.04 Range $1.60 - $2.66
Q3 2025
Shares 400,398 Value ($000) $889 Avg Close $1.63 Range $1.36 - $2.26
Q2 2025
Shares 496,216 Value ($000) $734 Avg Close $2.05 Range $1.32 - $3.10
Q1 2025
Shares 482,875 Value ($000) $1,236 Avg Close $2.39 Range $1.86 - $2.76
Q4 2023
Shares 70,990 Value ($000) $126 Avg Close $1.56 Range $1.21 - $1.90
Q3 2023
Shares 167,536 Value ($000) $278 Avg Close $1.79 Range $1.43 - $2.09
Q2 2023
Shares 115,539 Value ($000) $231 Avg Close $2.38 Range $1.90 - $3.55
Q1 2023
Shares 158,703 Value ($000) $333 Avg Close $1.75 Range $1.32 - $2.21